Literature DB >> 67081

Immunochemical studies on acetylcholine receptor from Torpedo californica.

A Aharonov, R Tarrab-Hazdai, I Silman, S Fuchs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 67081     DOI: 10.1016/0019-2791(77)90291-9

Source DB:  PubMed          Journal:  Immunochemistry        ISSN: 0019-2791


× No keyword cloud information.
  27 in total

1.  Prevention of passively transferred experimental autoimmune myasthenia gravis by a phage library-derived cyclic peptide.

Authors:  N Venkatesh; S H Im; M Balass; S Fuchs; E Katchalski-Katzir
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 2.  Immunopathologic events at the endplate in myasthenia gravis.

Authors:  T Ashizawa; S H Appel
Journal:  Springer Semin Immunopathol       Date:  1985

3.  A compilation of amino acid analyses of proteins : XVII. Residues per thousand residues-4.

Authors:  D M Kirschenbaumt
Journal:  Appl Biochem Biotechnol       Date:  1982-09       Impact factor: 2.926

4.  The alpha-bungarotoxin binding site on the nicotinic acetylcholine receptor: analysis using a phage-epitope library.

Authors:  M Balass; E Katchalski-Katzir; S Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 5.  Therapies Directed Against B-Cells and Downstream Effectors in Generalized Autoimmune Myasthenia Gravis: Current Status.

Authors:  Grayson Beecher; Brendan Nicholas Putko; Amanda Nicole Wagner; Zaeem Azfer Siddiqi
Journal:  Drugs       Date:  2019-03       Impact factor: 9.546

6.  Oral administration of an immunodominant T-cell epitope downregulates Th1/Th2 cytokines and prevents experimental myasthenia gravis.

Authors:  F Baggi; F Andreetta; E Caspani; M Milani; R Longhi; R Mantegazza; F Cornelio; C Antozzi
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

7.  Identification of synaptic acetylcholine receptor sites in retina with peroxidase-labeled alpha-bungarotoxin.

Authors:  Z Vogel; G J Maloney; A Ling; M P Daniels
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

8.  Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor alpha-subunit.

Authors:  D Barchan; M C Souroujon; S H Im; C Antozzi; S Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

9.  Identification of a hexapeptide that mimics a conformation-dependent binding site of acetylcholine receptor by use of a phage-epitope library.

Authors:  M Balass; Y Heldman; S Cabilly; D Givol; E Katchalski-Katzir; S Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

10.  The relation of clinical disease to antibody titre, proliferative response and neurophysiology in murine experimental autoimmune myasthenia gravis.

Authors:  A R Pachner; F S Kantor
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.